Inventor · disambiguated record
Lin Chen
Also filed as: CHEN LIN · CHEN LIN-WANYUE
7 granted patents·6 pending applications·5 citations·filing 2009–2023
74Inventor score
Top patents by PatentIndex Score
13 records- 0178US10106502B2Direct inhibitors of Keap1-Nrf2 interaction as antioxidant inflammation modulatorsUNIV RUTGERS·Filed 2017·Granted Oct 23, 2018·2 cites·11 claims
- 0276US9884101B2Treatment and prevention of malariaCHEN LIN·Filed 2015·Granted Feb 6, 2018·2 cites·3 claims
- 0367US9109040B2Treatment and prevention of malariaCHEN LIN·Filed 2011·Granted Aug 18, 2015·1 cites·10 claims
- 0467US2024100106A1Isolated recombinant oncolytic adenoviruses, pharmaceutical compositions, and uses thereof for drugs for treatment of tumors and/or cancersHANGZHOU CONVERD CO LTD·Filed 2023·Application pending·0 cites
- 0566US2022339220A1Therapeutic agents comprising oncolytic vaccinia viruses and nk cells, and uses thereof for drugs for treatment of tumors and/or cancersHANGZHOU CONVERD CO LTD·Filed 2022·Application pending·0 cites
- 0665US12193407B2Single factor modeling-constraint method and device for mice chronic fatigue syndromeUNIV WUHAN SCIENCE & TECH·Filed 2023·Granted Jan 14, 2025·0 cites·4 claims
- 0760US11806374B2Isolated recombinant oncolytic adenoviruses, pharmaceutical compositions, and uses thereof for drugs for treatment of tumors and/or cancersHANGZHOU CONVERD CO LTD·Filed 2018·Granted Nov 7, 2023·0 cites·26 claims
- 0860US11446345B2Therapeutic agents and uses thereof for drugs for treatment of tumors and/or cancersHANGZHOU CONVERD CO LTD·Filed 2018·Granted Sep 20, 2022·0 cites·15 claims
- 0951US9134311B2Methods and compositions for treating and preventing malaria using an invasion ligand directed to a protease-resistant receptorCOWMAN ALAN·Filed 2009·Granted Sep 15, 2015·0 cites·8 claims
- 1050US2014256767A1Direct inhibitors of keap1-nrf2 interaction as antioxidant inflammation modulatorsUNIV RUTGERS·Filed 2012·Application pending·0 cites
- 1144US2018028477A1Treatment of cardiac remodeling and other heart conditionsC & C BIOPHARMA LLC·Filed 2017·Application pending·0 cites
- 1243US2020289591A1Isolated Recombinant Oncolytic Poxvirus, Pharmaceutical Composition, and Use Thereof in Treatment of Tumors and/or CancerHANGZHOU CONVERD CO LTD·Filed 2018·Application pending·0 cites
- 1342US2016271083A1Treatment of cardiac remodeling and other heart conditionsC & C BIOPHARMA LLC·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lin Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →